RECRUITING

VCRC Tissue Repository

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to collect existing tissue specimens from subjects enrolled in Vasculitis Clinical Research Consortium (VCRC) studies. Analysis of these tissue specimens and linked clinical data collected through VCRC studies may lead to the identification and development of a series of translational research projects. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.

Official Title

VCRC Tissue Biorepository Collection Protocol

Quick Facts

Study Start:2016-11
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02967068

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * A participant will be deemed eligible for this study if the participant is/was enrolled in another one of the VCRC observational/longitudinal protocols (5502, 5503, 5504, 5505, 5506, 5507, 5563) and/or one of the VCRC interventional studies (5522, 5523, 5526, 5527, or 5562).
  1. * Inability to give informed consent (or their guardians in the case of children) and to sign the consent form.
  2. * Unwilling to allow the use of their tissue for research.

Contacts and Locations

Study Contact

Katie Doyle
CONTACT
Kathryn.Logue@pennmedicine.upenn.edu

Principal Investigator

Peter A Merkel, MD, MPH
STUDY_CHAIR
University of Pennsylvania

Study Locations (Sites)

Brigham and Women's Hospital
Boston, Massachusetts, 02115
United States
Boston University School of Medicine
Boston, Massachusetts, 02118
United States
Cleveland Clinic
Cleveland, Ohio, 44195
United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States
University of Pittsburgh
Pittsburgh, Pennsylvania, 15261
United States
University of Utah
Salt Lake City, Utah, 84132
United States

Collaborators and Investigators

Sponsor: University of Pennsylvania

  • Peter A Merkel, MD, MPH, STUDY_CHAIR, University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-11
Study Completion Date2025-12

Study Record Updates

Study Start Date2016-11
Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

  • CSS
  • EGPA
  • GCA
  • GPA
  • MPA
  • PAN
  • TAK
  • HSP

Additional Relevant MeSH Terms

  • Aortitis
  • Cutaneous Vasculitis
  • Eosinophilic Granulomatosis With Polyangiitis
  • Giant Cell Arteritis
  • Granulomatosis With Polyangiitis (Wegener's)
  • Henoch-Schonlein Purpura
  • IgA Vasculitis
  • Microscopic Polyangiitis
  • Polyarteritis Nodosa
  • Takayasu Arteritis
  • Churg-Strauss Syndrome